Situation: The public health nurse at a Barangay Health Station (BHS) follows up adults with asthma, chronic obstructive pulmonary disease (COPD), and hypertension who are listed in the barangay registry for noncommunicable diseases (NCDs). A 30-year-old woman with asthma has been prescribed an inhaled corticosteroid (ICS) as a controller. What should the nurse teach her to do after each dose?

Inhaled corticosteroids leave drug in the mouth and throat, which can cause oral candidiasis and dysphonia. Rinsing the mouth with water and spitting after each dose prevents this. The ICS controls airway inflammation over time and is not expected to relieve symptoms right away.

Why mouth rinsing is required after an inhaled corticosteroid

An inhaled corticosteroid (ICS) is a controller medication. It reduces airway inflammation gradually and does not act as a quick reliever. Because the drug is delivered directly into the oropharynx, a portion remains on the oral and pharyngeal mucosa after each inhalation. Residual ICS in the mouth causes local immunosuppression, which allows Candida albicans to overgrow and produces oropharyngeal candidiasis, hoarseness, and dysphonia. ^[1][3]

The correct instruction is to rinse the mouth with water and spit it out after every dose. This mechanically removes the drug deposited on the mucosa and reduces the risk of local fungal infection and voice changes. ^[1][2]

Watch out! The patient should spit out the rinse water. Swallowing it delivers the corticosteroid systemically and does not remove the drug from the oropharyngeal surface.

Key point! Rinsing is not needed to improve bronchodilation or to confirm the dose worked. It is a local hygiene measure to prevent adverse effects in the mouth and throat. ^[3]

Incorrect option	Why it is not the priority teaching
Take a reliever inhaler at once	An ICS is not a rescue medication. Taking a short-acting beta-agonist after every controller dose is unnecessary and may cause tremor or tachycardia.
Lie down and rest for 15 minutes	Rest does not remove residual drug from the oropharynx and does not prevent local candidiasis or dysphonia.
Check peak flow to confirm the effect	Peak flow monitoring assesses airway obstruction, but the anti-inflammatory effect of an ICS develops over days to weeks. A single post-dose peak flow reading cannot confirm controller efficacy.

The rinsing technique matters. In a study of budesonide delivered by Turbuhaler, gargling and rinsing removed measurable amounts of drug from the oropharyngeal mucosa, and repeating the rinse improved drug removal. ^[2] A separate survey of inpatients using ICS found that awareness of local adverse effects was linked to better gargling and rinsing habits, supporting the need for explicit patient teaching. ^[1]

For older adults who wear dentures, residual ICS can remain in the mouth and on the denture surface, so the rinse should include removing and cleaning dentures when applicable. In a 30-year-old adult without dentures, the core teaching remains the same: rinse with water and spit after each ICS dose.

The purpose of mouth rinsing is prevention of local adverse effects, not relief of acute asthma symptoms. The controller effect of the ICS continues even though the patient rinses afterward, because the drug that reaches the lower airways has already been deposited during inhalation. ^[3]